Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation
Author:
Affiliation:
1. Department of Neuroscience and Mental Health, Clinical Psychopharmacology Unit, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14740338.2017.1288716
Reference96 articles.
1. Paliperidone Extended-Release: Safety and Tolerability from a Metabolic Profile Perspective
2. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
3. Janicak P, Davis J, Preskorn S, et al. Principles and practice of psychopharmacotherapy. 4th. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 81–182.
4. Partial compliance in schizophrenia and the impact on patient outcomes
5. Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. D-Optimal Mixture Design Enabled Development of Lyophilized Nanoemulsifying Drug Delivery System of Paliperidone;Drug Delivery Letters;2024-06
2. Risk of Cardiovascular Events in Schizophrenic Patients Treated with Paliperidone Palmitate Once-Monthly Injection (PP1M): A Population-Based Retrospective Cohort Study in Taiwan;Clinical Drug Investigation;2024-04-15
3. Design, Development, Evaluation, and In Vivo Performance of Buccal Films Embedded with Paliperidone-Loaded Nanostructured Lipid Carriers;Pharmaceutics;2023-10-25
4. Barriers to the use of three-month Paliperidone Palmitate formulation: a study from an Italian real-world setting;Expert Review of Neurotherapeutics;2023-09-30
5. Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report;BMC Psychiatry;2022-11-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3